JT Pharmaceuticals Asset Purchase Agreement (Details) - JT Pharmaceuticals - USD ($) |
1 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Oct. 31, 2020 |
|
Asset Purchase Agreement [Line Items] | ||
Closing payment | $ 15,000,000 | |
Milestone Payments | $ 100,000 | |
Issuance of common stock, net (in shares) | 51,021 |
X | ||||||||||
- Definition Asset Purchase Agreement Line item. No definition available.
|
X | ||||||||||
- Definition This information is pertaining to the amount received a closing payment and is entitled to receive future milestone payments. No definition available.
|
X | ||||||||||
- Definition This information is pertaining to the amount received a closing payment and is entitled to receive milestone payments. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|